IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Joseph Harvey

London
As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Advertisement
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Singaporean firm creates co-investment group with animal health among targets

SEEDS Capital has brought together seven co-investment partners under a S$90 million ($66 million) platform focused on a range of agricultural markets, including animal health.

Investments Deals

Heska begins act two of evolution, purchases French endoscopy specialist

Heska will acquire an unnamed French business in the veterinary endoscopy equipment area.

Heska Deals

George Gunn points out the rising cost of innovation

Stonehaven Consulting founder and chief executive George Gunn has highlighted the new R&D model being adopted by animal health companies.

People R&D

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Steven St. Peter resigns, as Craig Tooman takes top job at Aratana

There has been a significant change at the top for Aratana Therapeutics, with Craig Tooman replacing Steven St. Peter.

Aratana Therapeutics People

Candioli to expand global reach of new UK acquisition

Italian companion animal health company Candioli aims to grow the European horizons of its latest acquisition.

Deals M&A
See All
Advertisement
UsernamePublicRestriction

Register